Background: Obsessive slowness, a symptom of obsessive-compulsive disorder (OCD), is characterized by compulsive behavior and significant slowness of movement. Primary obsessive slowness (POS) is defined as a condition in which a series of actions are segmented, and the patient spends an unlimited amount of time performing each action while checking each action, resulting in cessation or slowness of movement. It is often difficult to treat POS with exposure and response prevention, which is considered effective in general OCD, and no treatment has been established.
View Article and Find Full Text PDFCognitive processing therapy (CPT) is one of the most widely tested evidence-based treatments for posttraumatic stress disorder (PTSD). However, most studies on CPT have been conducted in Western cultural settings. This open-label, single-arm trial investigated the feasibility, acceptability, and preliminary efficacy of CPT for treating Japanese patients with PTSD.
View Article and Find Full Text PDFPurpose: Benzodiazepines (BZDs) are prescribed to treat psychiatric diseases. However, many guidelines recommend limiting the use of BZDs because of side effects and lack of evidence regarding long-term efficacy. Moreover, reducing BZDs' use is difficult because of dependency and the severity of withdrawal symptoms.
View Article and Find Full Text PDFNihon Arukoru Yakubutsu Igakkai Zasshi
February 2016
Purpose: The purpose of this study was to evaluate the efficacy of the Serigaya Methamphetamine Relapse Prevention Program (SMARPP), which is the workbook-based group therapy for individuals with drug dependence, through investigating 1-year follow-up outcomes.
Method And Subjects: The sample was drawn from 231 outpatients diagnosed as DSM-IV substance use disorder, who had firstly consulted the drug dependence clinic of the Center Hospital, National Center of Neurology and Psychiatry between September 2009 and June 2013. Of the 231 potential subjects, 79 had participated in SMARPP at least once, and finally 37 who had continued contact this clinic for more than 1 year after due-day of finishing the first SMARPP course were determined as the subjects.
Nihon Arukoru Yakubutsu Igakkai Zasshi
December 2014
In this study, we compared the efficacy of a group relapse prevention program using the cognitive behavioral therapy-based workbook, Serigaya Methamphetamine Relapse Prevention Program (SMARPP), between patients abusing the so-called "dappou drugs" (designer drug in Japan, and those abusing methamphetamine (MAP). Both groups participated in the SMARPP at the Center Hospital, National Center of Neurology and Psychiatry. Results showed that, no significant differences were found in the rates of participation in the program or self-reported frequency of drug or alcohol use between the patients abusing "dappou drugs" or MAP.
View Article and Find Full Text PDFAims: The purpose of the present study was to examine whether the possible effectiveness of the juvenile version of the Serigaya Methamphetamine Relapse Prevention Program (SMARPP-Jr.) self-teaching workbook we developed for relapse prevention of drug abuse depends on the severity of the subject's drug-related problems.
Methods: Subjects were 85 adolescent drug abusers who were detained in a juvenile classification home.
Background: There has been no relapse prevention program for drug dependent inmates in Japanese prisons. Recently, "Relapse Prevention Guidance" program is provided to the adult male inmates in Harima Rehabilitation Program Center (HRPC), one of the newly founded "Private Finance Initiative" prisons.
Aims: To evaluate the effectiveness of the program by comparing the outcomes between groups of inmates with different severity level of dependence.
Nihon Arukoru Yakubutsu Igakkai Zasshi
October 2010
In Japan, the Medical Treatment and Supervision Act (MTSA) has been in effect since 2005 as a new system for treating mentally disordered offenders. This system was anticipated to aim at treating schizophrenia, while preparing no treatment programs for Substance use disorder (SUD). However, unexpectedly 30% of the inpatients, who a court judged to be treated in this system, have co-occurring SUD in addition to mental disorders.
View Article and Find Full Text PDFNihon Arukoru Yakubutsu Igakkai Zasshi
October 2010
Objective: Assessment of the degree of motivation for change in drug abusers is important in determining the optimal treatment modality for each patient. The Stages of Change Readiness and Treatment Eagerness Scale (SOCRATES) is a 19 item instrument designed by Miller and Tonigan to provide quantitative assessment of the motivation for change in substance abusers. The object of the present study is to examine the factor structure and validity of the Japanese version of SOCRATES-8D (version 8 for drug abusers).
View Article and Find Full Text PDFNihon Arukoru Yakubutsu Igakkai Zasshi
June 2009
Aims: The purpose of the present study is to develop a relapse prevention tool for drug-abusing delinquents incarcerated in a juvenile classification home, and to evaluate effectiveness of the tool.
Methods: We prepared a self-teaching workbook for drug-abusing adolescents named "SMARPP-Jr." referring to the workbook used in the "SMARPP (Serigaya Methamphetamine Relapse Prevention Program)", and consulted about the contents of the workbook to the director, the medical doctor, and the psychologists of a juvenile classification home.
Psychiatry Clin Neurosci
February 2008
The present study examined the prevalence of self-injury and its association with substance abuse in 2974 junior and senior high-school students, by self-reporting questionnaires. Consequently, 9.9% of students (boys, 7.
View Article and Find Full Text PDFThe present study examined associations between childhood attention-deficit-hyperactivity disorder (ADHD) symptoms and adulthood dissociation in 799 male inmates using self-reporting questionnaires. Consequently, 33% of the subjects reported childhood physical abuse, and 11.8% reported childhood sexual abuse.
View Article and Find Full Text PDF